Clinical Trial Update: Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reports on safety, tolerability, and pharmacokinetics/pharmacodynamics of ADX-324 in healthy volunteers and hereditary angioedema patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• ADX-324

Snippet

Sponsor: ADARx Pharmaceuticals, Inc. | Conditions: Hereditary Angioedema | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING